Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation

Arthritis Care and Research

Volumn 62, Issue 12, 2010, Pages 3799-3805

  Huss, Ryan S ^a,b   Huddleston, James I ^a   Goodman, Stuart B ^a   Butcher, Eugene C ^a,b   Zabel, Brian A ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; CARBON TETRACHLORIDE; CELL SURFACE RECEPTOR; CHEMOATTRACTANT; CYTOKINE; RNA;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGRANULATION; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; JOINT PROSTHESIS; NATURAL KILLER CELL; OSTEOARTHRITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYNOVIUM; CONTROLLED STUDY; HUMAN TISSUE; INTERFERON PRODUCTION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; TISSUE LEVEL;

ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD56; ARTHROPLASTY, REPLACEMENT; CYTOKINES; HUMANS; INTERFERON-GAMMA; JOINT PROSTHESIS; KILLER CELLS, NATURAL; OSTEOARTHRITIS; OSTEOLYSIS; REOPERATION; SYNOVIAL MEMBRANE;

EID: 78649848766     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27751     Document Type: Article

References (15)

1. Schulte KR, Callaghan JJ, Kelley SS, Johnston RC,. The outcome of Charnley total hip arthroplasty with cement after a minimum twenty-year follow-up: the results of one surgeon. J Bone Joint Surg Am 1993; 75: 961-75.
2. Callaghan JJ, Bracha P, Liu SS, Piyaworakhun S, Goetz DD, Johnston RC,. Survivorship of a Charnley total hip arthroplasty: a concise follow-up, at a minimum of thirty-five years, of previous reports. J Bone Joint Surg Am 2009; 91: 2617-21.
3. Huddleston JI, Maloney WJ, Wang Y, Verzier N, Hunt DR, Herndon JH,. Adverse events after total knee arthroplasty: a national Medicare study. J Arthroplasty 2009; 24 (6 Suppl): 95-100.
4. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP,. The central role of wear debris in periprosthetic osteolysis. HSS J 2006; 2: 102-13.
5. - NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36: 118-28.
6. Pridgeon C, Lennon GP, Pazmany L, Thompson RN, Christmas SE, Moots RJ,. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright, CD158negative phenotype. Rheumatology (Oxford) 2003; 42: 870-8.
7. Dalbeth N, Callan MF,. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 2002; 46: 1763-72.
8. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166: 6477-82.
9. Iwamoto T, Okamoto H, Toyama Y, Momohara S,. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008; 275: 4448-55.
10. Spanogle JP, Miyanishi K, Ma T, Epstein NJ, Smith RL, Goodman SB,. Comparison of VEGF-producing cells in periprosthetic osteolysis. Biomaterials 2006; 27: 3882-7.
11. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007; 109: 3625-32.
12. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br 1999; 81: 155-62.
13. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005; 6: 928-37.
14. Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodstrom-Tullberg M, et al. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 2010; 184: 2272-80.
15. Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-Hermann E,. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996; 14: 155-62.